Thiopurine Methyltransferase (TPMT) Immunoassay


	Biologix Diagnostics
		Biologix Diagnostics, LLC is a subsidiary company of Biologix Research Company. Its mission is to acquire new clinical diagnosis-related technologies in their early stages of development and then proceed with the necessary commercialization to market the technologies to pharmaceutical, clinical, and diagnostic industries and communities.
	Since its establishment in August 2001, the company has a series of technologies/inventions under due diligence, acquisition, development, commercialization and marketing. At this time, Biologix is excited to introduce its new Thiopurine S-Methyltransferase (TPMT) Immunoassays (U.S. Patent No. 5856095). We are looking for a company to license this patented technology and bring the products to the U.S. and/or international market. Please visit its own website at http://www.TPMTassay.com for details.